MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, VVOS has $25,043K in assets. $26,310K in debts. $2,110K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
26.87%
Quick Ratio
26.87%
Cash Ratio
11.76%
Debt to Asset Ratio
105.06%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease right-of-use ass...
    • Intangible assets, net
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Current portion of debt
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
2,110 2,029 3,087 4,402
Accounts receivable, net of allowance of 1,159 and 882, respectively
1,769 1,581 2,134 1,633
Prepaid expenses and other current assets
940 774 565 695
Total current assets
4,819 4,384 5,786 6,730
Goodwill
8,572 8,572 8,450 8,450
Gross property and equipment
6,710 6,693 8,673 -
Less accumulated depreciation
3,184 2,936 3,031 -
Property and equipment, net
3,526 3,757 5,642 5,129
Operating lease right-of-use asset
4,033 4,166 3,383 3,244
Intangible assets, net
3,839 4,045 2,172 2,225
Deposits and other
254 228 211 255
Total assets
25,043 25,152 25,644 26,033
Accounts payable
1,996 1,679 2,103 1,763
Accrued expenses
6,113 5,988 2,682 2,302
Current portion of contract liabilities
495 479 537 480
Current portion of operating lease liability
744 672 734 654
Current portion of financing lease liability
56 55 55 55
Current portion of debt
7,299 8,353 339 157
Other current liabilities
1,234 850 987 1,015
Total current liabilities
17,937 18,076 7,437 6,426
Contract liabilities, net of current portion
--1 5
Employee retention credit liability
2,904 2,904 2,904 2,904
Operating lease liability, net of current portion
3,653 3,840 2,866 2,814
Financing lease liability, net of current portion
98 113 125 141
Debt, net of current portion
418 469 8,379 7,760
Other liabilities
1,300 1,300 1,400 1,400
Total liabilities
26,310 26,702 23,112 21,450
Common stock, 0.0001 par value per share. authorized 200,000,000 shares issued and outstanding 13,486,006 shares as of march 31, 2026 and 9,286,609 shares as december 31, 2025
1 1 1 -
Additional paid-in capital
131,900 123,866 120,995 117,647
Accumulated deficit
-133,039 -125,357 -118,464 -113,064
Total stockholders equity/(deficit)
-1,138 -1,490 2,532 4,583
Non-controlling interest
-129 -60 --
Total equity/(deficit)
-1,267 -1,550 --
Total liabilities and equity/(deficit)
25,043 25,152 25,644 26,033
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$2,110K Accounts receivable, netof allowance of...$1,769K Prepaid expenses andother current assets$940K Gross property andequipment$6,710K Goodwill$8,572K Total current assets$4,819K Operating leaseright-of-use asset$4,033K Intangible assets, net$3,839K Property and equipment,net$3,526K Deposits and other$254K Less accumulateddepreciation$3,184K Accumulated deficit-$133,039K Total assets$25,043K Total stockholdersequity/(deficit)-$1,138K Non-controlling interest-$129K Additional paid-in capital$131,900K Common stock, 0.0001par value per share....$1K Total liabilities andequity/(deficit)$25,043K Totalequity/(deficit)-$1,267K Total liabilities$26,310K Total currentliabilities$17,937K Operating leaseliability, net of current...$3,653K Employee retentioncredit liability$2,904K Other liabilities$1,300K Debt, net of currentportion$418K Financing leaseliability, net of current...$98K Current portion of debt$7,299K Accrued expenses$6,113K Accounts payable$1,996K Other currentliabilities$1,234K Current portion ofoperating lease liability$744K Current portion ofcontract liabilities$495K Current portion offinancing lease liability$56K

Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics, Inc. (VVOS)